Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-007542
Filing Date
2025-03-10
Accepted
2025-03-10 17:29:01
Documents
1
Period of Report
2025-03-06

Document Format Files

Seq Description Document Type Size
1 form4-03102025_090357.html 4  
1 form4-03102025_090357.xml 4 3390
  Complete submission text file 0001415889-25-007542.txt   4804
Mailing Address C/O AMPHASTAR PHARMACEUTICALS, INC. 11570 6TH STREET RANCHO CUCAMONGA CA 91730
Business Address
PETERS WILLIAM J (Reporting) CIK: 0001263136 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36509 | Film No.: 25725024

Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Issuer) CIK: 0001297184 (see all company filings)

EIN.: 330702205 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)